Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya. (Record no. 16006990)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02225 a2200649 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515012143.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200703s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0264-410X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.vaccine.2005.11.037 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Stoute, José A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20070302 |
245 00 - TITLE STATEMENT | |
Title | Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Vaccine |
Date of publication, distribution, etc. | Jan 2007 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 176-84 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S. |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adjuvants, Immunologic |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Protozoan |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Combinations |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kenya |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lipid A |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Malaria Vaccines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Malaria, Falciparum |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Merozoite Surface Protein 1 |
General subdivision | chemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Plasmodium falciparum |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Saponins |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gombe, Joash |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Withers, Mark R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Siangla, Joram |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | McKinney, Denise |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Onyango, Melanie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cummings, James F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Milman, Jessica |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tucker, Kathryn |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Soisson, Lorraine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stewart, V Ann |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lyon, Jeffrey A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Angov, Evelina |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Leach, Amanda |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cohen, Joe |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kester, Kent E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ockenhouse, Christian F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Holland, Carolyn A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Diggs, Carter L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wittes, Janet |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Heppner, D Gray |
773 0# - HOST ITEM ENTRY | |
Title | Vaccine |
Related parts | vol. 25 |
-- | no. 1 |
-- | p. 176-84 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.vaccine.2005.11.037">https://doi.org/10.1016/j.vaccine.2005.11.037</a> |
Public note | Available from publisher's website |
No items available.